Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patients.

Peter McGranaghanHans-Dirk DüngenAnshul SaxenaMuni RubensJoseph SalamiJasmin RadenkovicDoris BachSvetlana ApostolovicGoran LoncarMarija ZdravkovicElvis TahirovicJovan VeskovicStefan StörkEmir VeledarBurkert PieskeFrank EdelmannTobias Daniel Trippel

Published in: ESC heart failure (2020)

In patients with CHF, incorporating a panel of three metabolite-based biomarkers into a risk score improved the prognostic utility of NT-proBNP by predicting long-term cardiovascular death more precisely. This novel approach holds promise to improve clinical risk assessment in CHF patients.

Keyphrases

ejection fraction
risk assessment
end stage renal disease
newly diagnosed
prognostic factors
peritoneal dialysis
machine learning
deep learning